Login / Signup

Interaction of Ethanol and Oral ANS-6637, a Selective ALDH2 Inhibitor in Males: A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Cohort Study.

Stephanie S O'MalleyMegan J ShramNaama Levy-CoopermanBradley VincePeter M StrumphIvan DiamondBrent K Blackburn
Published in: Alcoholism, clinical and experimental research (2020)
A single oral dose of ANS-6637 with up to 5 standards drinks over 2.5 hours was generally well tolerated in healthy males. The most common pharmacological response was flushing and an increase in HR, which are known effects of acetaldehyde accumulation and consistent with inhibition of ALDH2 with oral ANS-6637 in combination with alcohol. The results of this alcohol interaction study support further testing of ANS-6637 in individuals who consume alcohol heavily.
Keyphrases
  • placebo controlled
  • double blind
  • alcohol consumption
  • clinical trial
  • study protocol
  • squamous cell carcinoma
  • radiation therapy
  • pulmonary artery
  • open label